共 9 条
- [1] Garlapati P., Qurie A., Granulomatosis with polyangiitis, StatPearls, (2024)
- [2] Greco A., Marinelli C., Fusconi M., Et al., Clinic manifestations in granulomatosis with polyangiitis, Int J Immunopathol Pharmacol, 29, 2, pp. 151-159, (2016)
- [3] Miloslavsky E.M., Lu N., Unizony S., Et al., Myeloperoxidase–antineutrophil cytoplasmic antibody (ANCA)–positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener’s): distinct patient subsets, Arthritis Rheumatol, 68, 12, pp. 2945-2952, (2016)
- [4] Robson J.C., Grayson P.C., Ponte C., Et al., 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis, Ann Rheum Dis, 81, 3, pp. 315-320, (2022)
- [5] Devaney K.O., Travis W.D., Hoffman G., Et al., Interpretation of head and neck biopsies in Wegener’s granulomatosis : a pathologic study of 126 biopsies in 70 patients, Am J Surg Pathol, 14, 6, pp. 555-564, (1990)
- [6] Szocs H.I., Torma K., Petrovicz E., Et al., Wegener’s granulomatosis presenting as pyoderma gangrenosum, Int J Dermatol, 42, 11, pp. 898-902, (2003)
- [7] Donmez S., Pamuk O.N., Gedik M., Et al., A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab, Int J Rheum Dis, 17, 4, pp. 471-475, (2014)
- [8] Schmieder S.J., Krishnamurthy K., Pyoderma gangrenosum, StatPearls, (2023)
- [9] Borda L.J., Wong L.L., Marzano A.V., Et al., Extracutaneous involvement of pyoderma gangrenosum, Arch Dermatol Res, 311, 6, pp. 425-434, (2019)